August 11, 2025 FDA Approves Ketamine Product for Surgical Pain Management PharmaTher has received FDA approval for KETARx, a ketamine therapy for surgical pain management. Conexiant
August 12, 2025 Is It Parkinson’s or Something Else? A Focused Clinical Guide to Early Referral Baptist Health South Florida
August 08, 2025 Potential New Second-Line Standard of Care Emerges in Small Cell Lung Cancer The ASCO Post
August 01, 2025 Use of Cemiplimab as Adjuvant Therapy for High-Risk Cutaneous Squamous Cell Carcinoma The ASCO Post
July 31, 2025 Perioperative Pembrolizumab Plus Surgery and Risk-Adapted Standard Adjuvant Therapy Shows Benefit in Locally Advanced Head and Neck Cancer The ASCO Post
August 05, 2025 Polatuzumab Vedotin–Based Regimen Improves Overall Survival in Refractory DLBCL The ASCO Post
June 19, 2025 Novel Tri-Specific Antibody Shows Efficacy and Safety in Refractory Myeloma The ASCO Post
June 19, 2025 Tafasitamab Plus Lenalidomide and Rituximab Significantly Improves Outcomes in Relapsed/Refractory Follicular Lymphoma The ASCO Post
August 12, 2025 Is It Parkinson’s or Something Else? A Focused Clinical Guide to Early Referral Baptist Health South Florida
August 12, 2025 Exonate Initiates Phase IIb Trial of EXN407 for Diabetic Eye Disease The Ophthalmologist
August 08, 2025 At the Forefront of Spine Surgery: Robotics, Biologics, & Clinical Trials at UCI Health UCI Health
August 08, 2025 At the Forefront of Spine Surgery: Robotics, Biologics, & Clinical Trials at UCI Health UCI Health